Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRO | REPL | FATE | ||
| Company | Spero Therapeutics Inc | Replimune Group Inc | Fate Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.78 | 1.9500 | 1.3400 | ||
| High | 2.80 | 2.2800 | 1.3600 | ||
| Low | 2.64 | 1.9200 | 1.2600 | ||
| Latest | 2.63 | 2.2700 | 1.2950 | ||
| Change | -0.15 | +0.3200 | -0.0450 | ||
| % Change | -5.40% | +16.41% | -3.36% | ||
| Volume | 582,678 | 10,601,802 | 1,195,332 | ||
| 20-Day Average Volume | 427,761 | 7,440,003 | 1,411,624 | ||
| Previous Close | 2.78 | 1.9500 | 1.3400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.51 | 6.3270 | 1.1945 | ||
| 20-Day Raw Stochastic | 67.91% | 9.86% | 58.54% | ||
| 20-Day Relative Strength | 57.51 | 27.32 | 52.66 | ||
| Weighted Alpha | +23.92 | -22.81 | -0.47 | ||
| Today's Opinion | 100% Buy | 88% Sell | 80% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 80% Buy | ||
| Last Month's Opinion | 64% Buy | 24% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.02% since 04/08/26 | -62.19% since 04/08/26 | +8.47% since 04/08/26 | ||
| Low | 2.63 on 04/10/26 | 1.5000 on 04/13/26 | 1.1800 on 04/09/26 | ||
| High | 2.88 on 04/14/26 | 6.6500 on 04/10/26 | 1.4500 on 04/13/26 | ||
| 1-Month | |||||
| %Chg | +3.29% since 03/13/26 | -68.84% since 03/13/26 | +9.40% since 03/13/26 | ||
| Low | 2.21 on 03/31/26 | 1.5000 on 04/13/26 | 1.0400 on 03/19/26 | ||
| High | 2.88 on 04/14/26 | 8.8500 on 04/06/26 | 1.4500 on 04/13/26 | ||
| 3-Month | |||||
| %Chg | +11.04% since 01/15/26 | -69.52% since 01/15/26 | +21.90% since 01/15/26 | ||
| Low | 2.10 on 02/03/26 | 1.5000 on 04/13/26 | 1.0400 on 03/19/26 | ||
| High | 2.88 on 04/14/26 | 9.1000 on 03/09/26 | 1.6950 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +7.03% since 10/15/25 | -53.06% since 10/15/25 | -16.34% since 10/15/25 | ||
| Low | 2.10 on 02/03/26 | 1.5000 on 04/13/26 | 0.9500 on 11/14/25 | ||
| High | 2.88 on 04/14/26 | 11.2600 on 12/02/25 | 1.9399 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 160,937 | 161,017 | 155,792 | ||
| Shares Outstanding, K | 57,891 | 82,573 | 116,263 | ||
| Annual Sales | 66,800,000 | 0 | 6,650,000 | ||
| Annual Net Income | 8,570,000 | -247,300,000 | -136,320,000 | ||
| Last Quarter Sales | 41,300,000 | 0 | 1,370,000 | ||
| Last Quarter Net Income | 31,520,000 | -70,930,000 | -32,370,000 | ||
| 60-Month Beta | 1.45 | 0.74 | 2.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.53 on 03/26/26 | -0.77 on 02/03/26 | -0.27 on 02/26/26 | ||
| Latest Earnings Date | 05/12/26 | 05/28/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 09/16/15 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.17 | 0.00 | 0.00 | ||